Review
BibTex RIS Cite
Year 2022, Volume: 9 Issue: 2, 203 - 214, 31.12.2022
https://doi.org/10.48138/cjo.1019435

Abstract

References

  • 1. Ahn DG., Shin HJ., Kim M., Lee S., Kim HS., Myoung J., Kim V., Kim SJ . (2020 ) Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 28 Mart 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
  • 2. Ahn DG., Shin HJ., Kim HM., Lee S., Kim HS., Myoung J., et al .(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
  • 3. Ak Ö. (2020). Soğuk Algınlığından Ölümcül Salgına Küresel Kâbus. Bilim ve Teknik Dergisi, 17-27.
  • 4. Akbaba M., Kurt B., Nazlıcan E.(2014). Yeni Koronavirüs Salgını. Türk J Public Health. 12(3):217-227.
  • 5. Al-Hazmi, A. (2016). Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences, 23(4): 507-511.
  • 6. Al-Tawfiq JA. (2013). Middle East respiratory syndrome- coronavirus infection: an overview. J Infect Public Health, 6(5):319-22.
  • 7. Briggs H. (2020). “Koronavirüs (Covid-19): Binlerce Kişinin Ölümüne Neden Olan Salgının Kaynağı Ne?” https://www.bbc.com/turkce/haberler-dunya-51624167.
  • 8. Caly L., Duruce DD., Catton MG., Jans DA., Wagstaff M.(2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, 104787.
  • 9. Cascella M., Rajnik M., Cuomo A., Dulebohn SC., Di Napoli R.(2020). Features, Evaluation and Treatment Coronavirus (COVID-19) . StatPearls. Treasure Island (FL): StatPearls Publishing.
  • 10. Contini C. , Nuzzo MD. , Barp N. , Bonazza A., Giorgio RD., Tognon M , et al.(2020). Yeni Zoonotik COVID-19 Salgını: Beklenen Küresel Sağlık Endişesi, J Bulaşıcı Geliştirme, 14 (3): 254-264.PMID: 32235085, DOI: 10.3855 / jidc.12671.
  • 11. Dae-Gyun A., Hye-Jin S., Mi-Hwa K .L., Hae-Soo K., Jinjong M ., Bum-Tae K et al.(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.

Yeni Coronavirüs SARS-CoV-2’nin Biyolojik Öyküsü Biological Story of the New Coronavirus SARS-CoV-2

Year 2022, Volume: 9 Issue: 2, 203 - 214, 31.12.2022
https://doi.org/10.48138/cjo.1019435

Abstract

Objective: The objective of this study is to gain knowledge about a new coronavirus Covis-19 epidemic that threatens public health. Method: “SARS-CoV-2” and “Coronavirus” keywords were searched in the Pubmed, Web of Science and Google Scholar databases and in the Google search engine; relevant articles were studied. Findings: This virus, called SARS-CoV-2, is a subspecies of a large family of viruses. But only seven, including the new virus, can infect human. The coronavirus outbreak that occurred in Wuhan, China, causing the disease called Covid-19, spread to almost all countries of the world, and caused a high number of deaths in a very short time. Conclusion: As of May 2020, there are no antiviral drug that treat the disease. Multidisciplinary studies are important to prevent information pollution about Covid-19 outbreak and to provide correct precaution and treatment. The data obtained from the researches in the wildlife will detect the viruses that may cause possible human and animal epidemics in the future.

References

  • 1. Ahn DG., Shin HJ., Kim M., Lee S., Kim HS., Myoung J., Kim V., Kim SJ . (2020 ) Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 28 Mart 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
  • 2. Ahn DG., Shin HJ., Kim HM., Lee S., Kim HS., Myoung J., et al .(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
  • 3. Ak Ö. (2020). Soğuk Algınlığından Ölümcül Salgına Küresel Kâbus. Bilim ve Teknik Dergisi, 17-27.
  • 4. Akbaba M., Kurt B., Nazlıcan E.(2014). Yeni Koronavirüs Salgını. Türk J Public Health. 12(3):217-227.
  • 5. Al-Hazmi, A. (2016). Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi Journal of Biological Sciences, 23(4): 507-511.
  • 6. Al-Tawfiq JA. (2013). Middle East respiratory syndrome- coronavirus infection: an overview. J Infect Public Health, 6(5):319-22.
  • 7. Briggs H. (2020). “Koronavirüs (Covid-19): Binlerce Kişinin Ölümüne Neden Olan Salgının Kaynağı Ne?” https://www.bbc.com/turkce/haberler-dunya-51624167.
  • 8. Caly L., Duruce DD., Catton MG., Jans DA., Wagstaff M.(2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro, 104787.
  • 9. Cascella M., Rajnik M., Cuomo A., Dulebohn SC., Di Napoli R.(2020). Features, Evaluation and Treatment Coronavirus (COVID-19) . StatPearls. Treasure Island (FL): StatPearls Publishing.
  • 10. Contini C. , Nuzzo MD. , Barp N. , Bonazza A., Giorgio RD., Tognon M , et al.(2020). Yeni Zoonotik COVID-19 Salgını: Beklenen Küresel Sağlık Endişesi, J Bulaşıcı Geliştirme, 14 (3): 254-264.PMID: 32235085, DOI: 10.3855 / jidc.12671.
  • 11. Dae-Gyun A., Hye-Jin S., Mi-Hwa K .L., Hae-Soo K., Jinjong M ., Bum-Tae K et al.(2020). Yeni Koronavirüs Hastalığı 2019 Epidemiyolojisi, Tanı, Terapötik ve Aşıların Mevcut Durumu 2019 (COVID-19), J Microbiol Biotechnol, 30 (3): 313-324. doi: 10.4014 / jmb.2003.03011.
There are 11 citations in total.

Details

Primary Language English
Subjects Environmental Sciences
Journal Section Articles
Authors

Aysel Güven 0000-0001-7511-7105

Publication Date December 31, 2022
Submission Date November 5, 2021
Acceptance Date December 29, 2022
Published in Issue Year 2022 Volume: 9 Issue: 2

Cite

APA Güven, A. (2022). Yeni Coronavirüs SARS-CoV-2’nin Biyolojik Öyküsü Biological Story of the New Coronavirus SARS-CoV-2. Caucasian Journal of Science, 9(2), 203-214. https://doi.org/10.48138/cjo.1019435

dizin1.png dizin2.png dizin3.png  dizin5.png dizin6.png dizin7.png